vTv Therapeutics (VTVT) Return on Sales Growth (3y) (2017 - 2026)
vTv Therapeutics (VTVT) Return on Sales Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 1.00 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 0.00 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 0.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 0.00 |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | vTv Therapeutics | 19.21 Mn | 19.21 Mn | - | 1,191.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,191.00 |
| Sep 30, 2025 | -1,655.00 |
| Jun 30, 2025 | -950.00 |
| Mar 31, 2025 | -1,343.00 |
| Dec 31, 2024 | 793.00 |
| Sep 30, 2024 | -22.00 |
| Jun 30, 2024 | 68.00 |
| Mar 31, 2024 | 0.00 |
| Sep 30, 2023 | -2,746.00 |
| Jun 30, 2023 | -1,640.00 |
| Mar 31, 2023 | -295.00 |
| Dec 31, 2022 | 306.00 |
| Sep 30, 2022 | 731.00 |
| Jun 30, 2022 | -452.00 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | -1,053.00 |
| Sep 30, 2021 | 0.00 |
| Jun 30, 2021 | -90.00 |
| Mar 31, 2021 | -1.00 |
| Dec 31, 2020 | 60.00 |